Radioiodine Ablation for Differentiated Thyroid Cancer-None, One Dose or Two?

被引：1
|
作者：
Rees, G. J. G. [1 ]
机构：
[1] Royal United Hosp, Canc Unit, Bath BA1 3NG, Avon, England
来源：
CLINICAL ONCOLOGY | 2010年 / 22卷 / 02期
关键词：
Guidelines; radioiodine; thyroid cancer; 2ND PRIMARY MALIGNANCIES; IODINE REMNANT ABLATION; RANDOMIZED-TRIAL; CARCINOMA; THERAPY; I-131; PAPILLARY; RISK; METAANALYSIS; METASTASES;
D O I：
10.1016/j.clon.2009.11.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Patients with good prognosis differentiated thyroid cancer are at risk from over-treatment with radioiodine thyroid remnant ablation. Some with unfavourable localised disease might benefit from an elective second dose. (C) 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：131 / 135
页数：5
相关论文
共 50 条
  • [21] Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer
    Bal, CS
    Kumar, A
    Pant, GS
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (02) : 203 - 208
  • [22] Quality of Life Survey Following Radioiodine Ablation in Patients with Differentiated Thyroid Cancer
    Nikoleta Gkatzia
    Angelos Papadopoulos
    Petros Kostagiolas
    Theodoros Karianos
    Sofia Saranti
    SN Comprehensive Clinical Medicine, 2021, 3 (1) : 158 - 165
  • [23] Therapeutic efficacies of remnant ablation and radioiodine adjuvant therapy in differentiated thyroid cancer
    Liu, Yanlin
    Huang, Shuhui
    Li, Xiaohui
    Tian, Tian
    Huang, Rui
    ENDOCRINE, 2025, 87 (02) : 734 - 743
  • [24] Fractionated dosage of radioiodine for the ablation of differentiated thyroid carcinoma
    Czepczynski, R
    Ziemnicka, K
    Baczyk, M
    Oleksa, R
    Ruchala, M
    Sowinski, J
    THYROID, 2005, 15 (11) : 1261 - 1265
  • [25] Radioiodine refractory differentiated thyroid cancer
    Jin, Yuchen
    Van Nostrand, Douglas
    Cheng, Lingxiao
    Liu, Min
    Chen, Libo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 111 - 120
  • [26] Radioiodine refractory differentiated thyroid cancer
    Boudina, Maria
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2023, 26 : 65 - 68
  • [27] Radioiodine treatment for differentiated thyroid cancer
    Vini, L
    Harmer, C
    CLINICAL ONCOLOGY, 2000, 12 (06) : 365 - 372
  • [28] Evaluation of high-dose radioiodine therapy in differentiated and poorly differentiated metastatic thyroid cancer
    Enzian, M.
    Hering, A. H.
    Odparlik, A.
    Bahre, M.
    Meller, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S500 - S500
  • [29] Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
    Mallick, Ujjal
    Harmer, Clive
    Yap, Beng
    Wadsley, Jonathan
    Clarke, Susan
    Moss, Laura
    Nicol, Alice
    Clark, Penelope M.
    Farnell, Kate
    McCready, Ralph
    Smellie, James
    Franklyn, Jayne A.
    John, Rhys
    Nutting, Christopher M.
    Newbold, Kate
    Lemon, Catherine
    Gerrard, Georgina
    Abdel-Hamid, Abdel
    Hardman, John
    Macias, Elena
    Roques, Tom
    Whitaker, Stephen
    Vijayan, Rengarajan
    Alvarez, Pablo
    Beare, Sandy
    Forsyth, Sharon
    Kadalayil, Latha
    Hackshaw, Allan
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (18): : 1674 - 1685
  • [30] Radioiodine low-dose for remnant ablation in differentiated thyroid carcinoma: considerations of a pilot study
    Burroni, L.
    Castagna, M. G.
    Cipri, C.
    Pacini, F.
    Vattimo, A. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S421 - S421
12345